1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Cannonau Corp.

Cannonau Corp.

CNNC
Cannonau Corp.US flagOther OTC
0.00
USD
- -
- -
48,275.00Market Cap
Cannonau Corp.
CNNC
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Revenue per Share
-1.63
-5.76
-99.77
-62.28
- -
- -
- -
- -
- -
- -
- -
-1.48
- -
- -
- -
- -
- -
Basic EPS, GAAP
-1.67
-1.88
-70.64
-21.1
- -
- -
- -
- -
- -
- -
- -
-1.78
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-0.29
-6.03
-105.25
-163.39
-163.39
-163.39
-163.39
-163.39
-163.39
-163.39
-165.37
-69.27
-0.03
-0.01
-0.01
- -
-0.01
Book Value per Share
-0.29
-1.33
64.48
-0.34
-0.34
-0.34
-0.34
-0.34
-0.34
-0.34
-0.34
-1.56
- -
- -
- -
- -
- -
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
127
241
242
- -
242
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-4,715.69
-2,405.15
-37,863.44
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
-2
-1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-4,715.69
-2,405.15
-37,863.44
- -
- -
Profit Margin (%)
- -
- -
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
- -
- -
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-10.02
-10.32
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'23
Dec'23
Mar'24
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
242
242
242
Market Capitalization
3
4
2

Working Capital

FRC

•

in mil. unless spec.
Sep'23
Dec'23
Mar'24
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
-99.82%
Net Income, GAAP
- -
- -
-493.53%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
Similar Companies
Beximco Pharmaceuticals Limited (BXP.L)
Hunan Hansen Pharmaceutical Co., Ltd. (002412.SZ)
Laurus Labs Limited (LAURUSLABS.NS)
Verano Holdings Corp. (VRNOF)
Vivimed Labs Ltd. (VIVIMEDLAB.NS)
Chalice Brands Ltd. (CHAL.CN)
Business
Cannonau Corp. (CNNC) develops and provides cannabidiol (CBD)-based products for consumer wellness markets. The company offers a range of CBD formulations, including oils, topicals, oil sprays and gummies; it operates within the pharmaceuticals and biotechnology industry, targeting health and wellness customers primarily in the United States. Cannonau Corp. was founded in 2007 and is headquartered at 937 Old Seneca Turnpike Road in Skaneateles, New York. The company, formerly known as Pacific Blue Energy Corp., underwent a significant name change to Cannonau Corp. in August 2019 to align with its strategic shift from energy exploration to CBD product development. No recent partnerships, funding rounds, acquisitions, new product launches or major expansions have been publicly announced in the last 1-2 years.